Concentrix Corp - WI

Concentrix stock performance improves, rating upgraded

Concentrix has exhibited a positive trend in its price performance, resulting in an upgrade to its IBD Relative Strength Rating. The company's stock has shown improvement, leading to this upgrade. This signifies a positive development in the stock's performance and suggests potential growth in its value.

Concentrix stock receives a Relative Strength Rating upgrade, indicating improving price performance.

Bank of America has raised its target price for Concentrix (NASDAQ:CNXC) from $59.00 to $65.00, maintaining a "neutral" rating, indicating a potential upside of 14.46%. Meanwhile, Barrington Research lowered its target from $70.00 to $54.00 with an "outperform" rating. Concentrix's stock is currently trading at $56.79, with a market cap of $3.63 billion. The company reported $2.79 EPS for the last quarter, exceeding estimates, but revenue declined by 1.3% year-over-year. Insider transactions include CEO Caldwell acquiring shares, while EVP Twomey sold some shares recently.

Bank of America Forecasts Strong Price Appreciation for Concentrix (NASDAQ:CNXC) Stock

Concentrix (CNXC) has received mixed analyst ratings over the past three months, with an average 12-month price target of $58.00, down from $60.25. Analysts' evaluations range from 'Outperform' to 'Underperform', reflecting varied expectations. The company faces challenges with a revenue decline of -1.27%, a net margin of 2.82%, and ROE and ROA below industry averages. Despite a balanced debt-to-equity ratio of 1.22, Concentrix's market capitalization is below industry norms, indicating potential hurdles in financial performance and growth.

Analyst Expectations For Concentrix's Future

Concentrix Co. (NASDAQ:CNXC) EVP Cormac J. Twomey sold 500 shares at $57.06 each, totaling $28,530, reducing his ownership by 1.29% to 38,130 shares valued at approximately $2.18 million. The company reported a quarterly EPS of $2.79, beating estimates, with a revenue of $2.37 billion. Concentrix also announced a quarterly dividend of $0.3328, yielding 2.43%. Analysts have mixed ratings, with a consensus "Buy" and an average target price of $58.75.

Concentrix stock performance improves, rating upgraded

Summary

Impact Analysis